Search Results 3611-3620 of 23474 for oral

  1. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    agents, oral calcineurin inhibitors, or high-potency or oral corticosteroids within the previous 12 months - History of idiopathic pulmonary fibrosis ...

  2. Azithromycin (ophthalmic route) - Mayo Clinic

    Azithromycin eye drops is used to treat infections of the eye, including bacterial conjunctivitis. Azithromycin belongs to a group of medicines called macrolide ...

  3. Dr. Adrian Vella Archives - Mayo Clinic News Network

    acarbose). Furthermore, by confining the recommendations to oral medications, another class of injectable medication – glucagon-like peptide-1 receptor agonists ...

  4. Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) - Mayo Clinic

    - Orally administered CYP3A4 substrates and MATE and OAT3 substrates ... oral dose in healthy volunteers. Barbour AM. April M; Sarov-Blat L. Lea; Cai ...

  5. A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

    Oral corticosteroids (≤ 10 mg/day of prednisone or equivalent) and NSAIDs are permitted if the patient is on a stable dose regimen for. 2 weeks prior to and ...

  6. Parathyroidectomy - Doctors & Departments - Mayo Clinic

    oral laser microsurgery, Facial reconstruction, Parotid gland surgery ... ructive surgery, Oral surgery, Skin cancer excision, Microvascular ...

  7. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  8. Tiny But Mighty, Lorelei Overcomes Devastating Digestive Disease - Mayo Clinic News Network

    Again, oral feedings ceased, and IV antibiotics and IV nutrition started. Fourteen days later, oral feedings resumed. Again, Lorelei struggled to eat. "She ...

  9. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab - Mayo Clinic

    ... oral corticosteroid (OCS) dose \<=7.5 mg/day of prednisolone or equivalent, following standard induction regimen for at least 3 months and within 6 months ...

  10. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.